Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program - Wikidata - wikimedia - TriplyDB

Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program

Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program

http://www.wikidata.org/entity/Q28201111

about

The bitter fate of the sweet heart: impairment of iron homeostasis in diabetic heart leads to failure in myocardial protection by preconditioning.The Loss of Myocardial Benefit following Ischemic Preconditioning Is Associated with Dysregulation of Iron Homeostasis in Diet-Induced Diabetes.Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis.Dietitian-coached management in combination with annual endocrinologist follow up improves global metabolic and cardiovascular health in diabetic participants after 24 months.

P2860

Q34729946-05A58B3C-F9E0-4FA5-A4E2-A9C66116ADCE Q36085711-C9142E1E-5650-4F3B-9F22-73E993F9D1C7 Q39006092-0835675B-BD16-444E-8C7F-2031BC1D8A95 Q51183348-C9431441-7EE4-438F-B6A6-EF0B0CA7F3AC

P2860

Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program

http://www.wikidata.org/entity/Q28201111

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@ast

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@en

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@nl

type

label

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@ast

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@en

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@nl

prefLabel

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@ast

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@en

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@nl

P1433

Q28201111-6B0DDFD3-B9C0-4E8B-8631-E5F5FEB01133

P1476

Q28201111-1287987E-0682-4FA3-930C-555C06A52245

P2093

Q28201111-64FE2108-C10E-4515-8618-CC580500CF28

Q28201111-B314049B-5028-4420-8D7D-F70BC1795085

Q28201111-C2742D25-13E3-4866-B4F4-964ACF71B383

Q28201111-D8BA8E70-D44F-4DA4-B7EB-ACBEA54DBDE3

P2860

Q28201111-13F7D61A-A839-4E20-88B2-E5ED97EA226E

Q28201111-15F1EC56-D900-49B1-9FBB-138C57A1BA29

Q28201111-1C4B18A5-2CE0-44CC-B1CF-B94E4FD9F11F

Q28201111-2401C5E0-A9F6-4B27-BD39-D4C4EFBC770D

Q28201111-285DD75A-3FD2-4B49-A22C-37F12C41CD76

Q28201111-36946DA7-3601-45C5-A0C2-EAAB1536A44F

Q28201111-62BEB908-6E01-46C6-8F5F-59B40AA20670

Q28201111-652C635F-3BA0-48B6-A1D8-5FEF66B20E0E

Q28201111-65C05C96-ACA1-4ADB-8ECE-0613D7954B09

Q28201111-6EE76650-3C9A-4359-9BF7-14CAA60F9984

P304

Q28201111-92873F4E-B422-4255-AEBB-4DA6BA185725

P31

Q28201111-ADF39F78-D604-43B0-9A5E-E1F696F33E6C

P3181

Q28201111-40E615E0-732C-4EE8-9F05-0409CA6ED1D0

P356

Q28201111-10C009BB-50F3-41F1-92D9-4F9DE051A167

P407

Q28201111-D43E9ABA-1799-4D70-9346-102AE85EEFD2

P433

Q28201111-E1EC69DE-288A-40B7-8784-4C028CB97DCD

P478

Q28201111-7BEBEDAB-6E78-43E1-BBBF-CDA102066EAF

P577

Q28201111-3AFE016D-29D0-4AFC-9EDF-47816843A384

P698

Q28201111-C070F59E-47D0-45D9-A5F3-C28C7930A348

P921

Q28201111-F5B8FB80-5AD2-476C-B34A-39845FDA4C40

P3181

P356

J.1745-7599.2006.00171.X

P1433

Journal of the American Academy of Nurse Practitioners

P1476

Reducing cardiovascular diseas ...... nal Diabetes Education Program

@en

P2093

Elizabeth Warren-Boulton

http://www.w3.org/2001/XMLSchema#string

Joanne M Gallivan

http://www.w3.org/2001/XMLSchema#string

Judith Dempster

http://www.w3.org/2001/XMLSchema#string

Lawrence Blonde

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

P304

524-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4402318

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1745-7599.2006.00171.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17064330

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease